2. Gene
  3. Fes - feline sarcoma oncogene Gene

Fes - feline sarcoma oncogene Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as FPS; c-fes

Gene ID: 14159 | Gene type: protein coding

About Fes

Summary

Enables microtubule binding activity and protein kinase activity. Acts upstream of or within centrosome cycle and microtubule bundle formation. Located in microtubule Cytoskeleton. Is expressed in central nervous system and retina. Orthologous to human FES (FES proto-oncogene, tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]

Fes Products(1)

mRNA Protein Name
NM_010194.2 NP_034324.2 tyrosine-protein kinase Fes/Fps
Gene Ontology
  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Reference Source
enables microtubule binding IDA
IDA: Inferred from direct assay
14551201 MGI
enables protein binding IPI
IPI: Inferred from physical interaction
22522491 MGI
enables protein kinase activity IDA
IDA: Inferred from direct assay
12192036 MGI
Biological Process GO Annotation Evidence Reference Source
acts upstream of or within centrosome cycle IMP
IMP: Inferred from mutant phenotype
14551201 MGI
acts upstream of or within microtubule bundle formation IDA
IDA: Inferred from direct assay
14551201 MGI
Cellular Component GO Annotation Evidence Reference Source
located in microtubule cytoskeleton IDA
IDA: Inferred from direct assay
14551201 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

tyrosine-protein kinase Fes/Fps

proto-oncogene c-Fes

proto-oncogene tyrosine-protein kinase Fes/Fps

tyrosine kinase Fps/Fes

Related Agents

Approval
Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0988 Deferoxamine mesylate 99.94% Unkown
HY-B1625 Deferoxamine 99.76% Yes
HY-16168A Degarelix 99.94% Unkown
HY-107928 Iron dextran / Unkown
HY-17609 Difelikefalin Agonist 99.50% Unkown
HY-B1306 4-Aminohippuric acid 99.84% Unkown
HY-16564 Deferasirox (Fe3+ chelate) Inhibitor ≥98.0% Unkown
HY-108017 Ferric maltol 99.93% Yes
HY-16168B Degarelix acetate hydrate / Unkown
HY-16168 Degarelix acetate Antagonist / Unkown
Clinical Phase
Bioactive Molecules (7)
Cat. No. Product Name Effect
Purity Phase
HY-12040 Elesclomol 99.80% Phase 3
HY-P1714 Apraglutide 99.33% Phase 3
HY-105239A Selepressin acetate Agonist 98.77% Phase 3
HY-P1714A Apraglutide TFA 98.69% Phase 3
HY-105239 Selepressin Agonist 99.34% Phase 3
HY-122844 Ifebemtinib Inhibitor 99.86% Phase 2
HY-P3516 Barusiban Antagonist / Phase 2
Pre-clinical Phase
Bioactive Molecules (65)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-D1533 RhoNox-1 98.54% Unkown
HY-W004544 o-Phenanthroline Inhibitor 99.96% Unkown
HY-137805 Ferrozine 99.96% Unkown
HY-126823 Phen Green SK diacetate (5/6-mixture) 95.33% Unkown
HY-N0928 Mimosine Inducer 99.92% Unkown
HY-D1913 FerroOrange 98.2% Unkown
HY-N10473 Pulcherriminic acid Inhibitor ≥98.0% Unkown
HY-W075707 FeTCPP chloride ≥95.0% Unkown
HY-145157 Ferric nitrilotriacetate ≥98.0% Unkown
HY-D0945 Xylene Cyanol FF 97.46% Unkown
HY-Y1841 o-Phenanthroline monohydrate Inhibitor 99.38% Unkown
HY-128525 Enterobactin Inhibitor 99.64% Unkown
HY-P3267A Apo-Bovine Transferrin Activator ≥95.0% Unkown
HY-163897 PROTAC NCOA4 degrader-1 Inhibitor 99.42% Unkown
HY-D0221 2,4,6-Tri-2-pyridinyl-1,3,5-triazine 99.87% Unkown
HY-156776 HAPSBC ≥95.0% Unkown
HY-B1250 Acedoben 99.42% Unkown
HY-N0046 Notoginsenoside Fe 99.94% Unkown
HY-136300 PHD-1-IN-1 Inhibitor 99.21% Unkown
HY-145286 IMPDH2-IN-2 99.73% Unkown
HY-155539 Cisd2 agonist 2 Agonist 99.17% Unkown
HY-158779 Sulfane sulfur probe 4 97.3% Unkown
HY-158739 Rhodamine dithenoyl hydrazide 98.00% Unkown
HY-B1250A Acedoben sodium 99.99% Unkown
HY-W015600 2-Acetamidophenol 99.48% Unkown
HY-B1159S Nitroxoline-d4 / Unkown
HY-107928B Iron–Dextran(Fe 35-40% w/w) / Unkown
HY-160414 TRX-COBI Inhibitor / Unkown
HY-B1306S 4-Aminohippuric acid-d4 ≥98.0% Unkown
HY-W112021 2,5-DMBQ 99.99% Unkown
HY-W112939 Fe(III)(TDCPP) chloride 95.00% Unkown
HY-100332 CP 375 / Unkown
HY-115832 Ap44mSe / Unkown
HY-138185 Collismycin A Inhibitor / Unkown
HY-143249 MtMetAP1-IN-1 Inhibitor / Unkown
HY-149418 BChE/HDAC6-IN-2 Inhibitor / Unkown
HY-155158 Anticancer agent 147 Inducer / Unkown
HY-157917 Nitro-PAPS disodium dihydrate / Unkown
HY-157926 Nitroso-PSAP / Unkown
HY-159943 ROS151 Inhibitor / Unkown
HY-16168AS Degarelix-d7 Antagonist / Unkown
HY-162812 H3R antagonist 4 Inhibitor / Unkown
HY-162933 AChE-IN-77 Inhibitor / Unkown
HY-170433 DefNEtTrp Inducer / Unkown
HY-172092 BG11 Inducer / Unkown
HY-D2204 SHP1-IN-1 Inhibitor / Unkown
HY-D2730 N14G-Fe Inhibitor / Unkown
HY-E70311 TLL-10X / Unkown
HY-N13871 Anguibactin Inhibitor / Unkown
HY-RS04867 FES Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W004544S o-Phenanthroline-d8 Inhibitor / Unkown
HY-W011816 1,2-Hexadecanediol 99.73% Unkown
HY-W686216 VK-28 97.17% Unkown
HY-148340 24RBPyBC / Unkown
HY-17609C Difelikefalin acetate Agonist / Unkown
HY-17609S Difelikefalin-d5 Agonist / Unkown
HY-N14059 Halymecin B / Unkown
HY-N14060 Halymecin C / Unkown
HY-N15282 Broussoflavonol G / Unkown
HY-N15310 Dimerum acid / Unkown
HY-N15398 Chaetoglobosin E Inducer / Unkown
HY-RS18447 Fes Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS24929 Fes Rat Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W009022 Diantipyrylmethane 98.98% Unkown
HY-W151629A Ferrozine sodium hydrate / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Fes NCBI NCBI:2242